Drug Profile
Research programme: factor VIIa inhibitors - Molecumetics/Asahi
Alternative Names: Factor VIIa inhibitors research programme - Molecumetics/Asahi; MOL 2591Latest Information Update: 04 Sep 2000
Price :
$50
*
At a glance
- Originator Molecumetics
- Developer Asahi Kasei; Molecumetics
- Class
- Mechanism of Action Factor VIIa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Blood coagulation disorders
Most Recent Events
- 04 Sep 2000 Discontinued-Preclinical for Coagulation disorders in Japan (PO)
- 04 Sep 2000 Discontinued-Preclinical for Coagulation disorders in USA (PO)
- 19 Nov 1997 New profile